269 related articles for article (PubMed ID: 15897574)
1. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
2. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
Horlings HM; van Laar RK; Kerst JM; Helgason HH; Wesseling J; van der Hoeven JJ; Warmoes MO; Floore A; Witteveen A; Lahti-Domenici J; Glas AM; Van't Veer LJ; de Jong D
J Clin Oncol; 2008 Sep; 26(27):4435-41. PubMed ID: 18802156
[TBL] [Abstract][Full Text] [Related]
4. Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin.
Dennis JL; Vass JK; Wit EC; Keith WN; Oien KA
Cancer Res; 2002 Nov; 62(21):5999-6005. PubMed ID: 12414618
[TBL] [Abstract][Full Text] [Related]
5. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
Shield PW; Koivurinne K
Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic strategies for unknown primary cancer.
Varadhachary GR; Abbruzzese JL; Lenzi R
Cancer; 2004 May; 100(9):1776-85. PubMed ID: 15112256
[TBL] [Abstract][Full Text] [Related]
7. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
8. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
Park SY; Kim BH; Kim JH; Lee S; Kang GH
Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593
[TBL] [Abstract][Full Text] [Related]
9. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin.
Azoulay S; Adem C; Pelletier FL; Barete S; Francès C; Capron F
J Cutan Pathol; 2005 Sep; 32(8):561-6. PubMed ID: 16115055
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic yield of tumor markers in cancer of unknown primary site.
Parvez T; Ibraheim MI
J Coll Physicians Surg Pak; 2006 Feb; 16(2):154-6. PubMed ID: 16499817
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
12. Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach.
DeYoung BR; Wick MR
Semin Diagn Pathol; 2000 Aug; 17(3):184-93. PubMed ID: 10968704
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
Brown RW; Campagna LB; Dunn JK; Cagle PT
Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
[TBL] [Abstract][Full Text] [Related]
14. Identifying tumor origin using a gene expression-based classification map.
Buckhaults P; Zhang Z; Chen YC; Wang TL; St Croix B; Saha S; Bardelli A; Morin PJ; Polyak K; Hruban RH; Velculescu VE; Shih IeM
Cancer Res; 2003 Jul; 63(14):4144-9. PubMed ID: 12874019
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
[TBL] [Abstract][Full Text] [Related]
16. [An immunohistological study of metastatic adenocarcinoma of the lymph node: is it useful in diagnosing a primary tumor?].
Hamaya K; Doi K; Yoshizawa S; Motoi M
Gan No Rinsho; 1988 Nov; 34(14):1956-60. PubMed ID: 2462648
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical flow chart to differentiate between primary adenocarcinoma and the most frequent extragynecological metastases in the ovary].
Pires Y; Andrade L; Cuello M; Chuaqui R
Rev Med Chil; 2002 Nov; 130(11):1232-40. PubMed ID: 12587505
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; McMillan A
Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
[TBL] [Abstract][Full Text] [Related]
19. [Unknown primary tumour--diagnostic strategies and treatment].
Møller AK; Gundgaard MG; Petersen BL; Daugaard G
Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
[TBL] [Abstract][Full Text] [Related]
20. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]